Benjamin G. Trist is a neurologist based in Sydney, NSW 2006, Australia. His work looks after people living with long-term nerve and movement conditions. Neurology can feel a bit overwhelming at first, so appointments are usually focused on clear answers, practical next steps, and making sure families understand what to expect.
Benjamin provides care for amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig’s disease. He also looks after people with primary lateral sclerosis (PLS). These conditions affect the nervous system and can change over time. In many cases, the goal is to manage symptoms, support day-to-day function, and help people plan ahead as their needs change.
He also works with people who have movement disorders. This can include problems like tremor, stiffness, slowness of movement, and changes in how the body controls movement. Parkinson’s disease is one of the main conditions he treats. For Parkinson’s, symptoms can vary from person to person, even in the same day. At times, that means adjusting treatment plans to suit how someone is getting on, not just what the calendar says.
Neurological care is not only about medicines, either. It often involves coordinating with other health professionals so care stays steady and sensible. That can include support for mobility, sleep, and swallowing concerns in the context of conditions like ALS and PLS. For movement disorders, it can also mean looking at balance, falls risk, and how someone is coping with daily activities.
Benjamin’s clinic time is built around listening first. People may come in with questions about new symptoms, worries about progression, or trouble coping with day-to-day changes. From there, the conversation can move to what can be done now, what can be watched for later, and when to seek help sooner.
If you’re looking for a neurologist in Sydney who understands serious nerve conditions and movement disorders, Benjamin G. Trist is based in Sydney, NSW 2006 and works with patients dealing with ALS, PLS, movement disorders, and Parkinson’s disease.